Silymarin nanoparticles counteract cognitive impairment induced by doxorubicin and cyclophosphamide in rats; Insights into mitochondrial dysfunction and Nrf-2/HO-1 axis
Fatma G Aboelnasr, Mina Y. George, Maha Nasr, Esther T. Menze
Topics & Concepts
PharmacologyDoxorubicinCognitive impairmentCyclophosphamideMitochondrionChemistryMedicineCognitionInternal medicineBiochemistryChemotherapyPsychiatryCancer-related cognitive impairment studiesGraphene and Nanomaterials ApplicationsCarbon and Quantum Dots Applications